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Introduction
Dizocilpine (MK-801) (1) is an antagonist of the N-methyl-D-
aspartate receptor in the glutamate category involved with the 
central nervous system (CNS). The drug displays a variety of 
physiological actions, many of which involve the CNS, such as 
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Dizocilpine (MK-801), an extensively investigated drug possess-
ing secondary amine and benzenoid functions, displays a wide 
array  of  biological  properties,  including  anticonvulsant  and   
anesthetic.  There  is  scant  discussion  of  biomechanism.   
A relevant, important finding is formation of oxidative metab-
olites in the hydroxylamine and phenolic categories. Analogy 
to cocaine metabolites suggests participation of redox enti-
ties, such as, hydroxylamine, nitroxide and nitrosonium, which 
can lead to electron transfer and radical formation. There is 
also similarity to metabolism by 3,3'-iminodipropionitrile and 
phencyclidine. Alternatively, the phenolic metabolites are well-
known precursors of ET quinones. The review documents vari-
ous physiological effects, mainly involving the central nervous 
system. Also of interest are the pro- and anti-oxidant proper-
ties. Considerable attention has been paid to MK-801 as an 
antagonist of the N-methyl-D-aspartate receptor in the gluta-
mate category. This aspect is often associated with effects on 
the central nervous system. The review also provides recent 
literature dealing with MK-801/NMDA receptor in various ar-
eas of bioactivity. Studies were made of MK-801 involvement in 
working memory processing. Deficits in behavior were noted 
after administration of the drug. Treatment of mice with dizo-
cilpine induced learning impairment. The influence of MK-801 
on fear has been investigated. The substance is known to exert 
an analgesic effect in pain control. A number of reports deal 
with anesthetic properties.
REVIEW  REVIEW
anesthetic and anticonvulsant properties. The bioactivity is dis-
cussed within the framework of a unifying mechanistic theme 
which has been discussed in prior reviews.
The preponderance of bioactive substances and their metabo-
lites incorporate electron transfer (ET) functionalities, which, 
we believe, play an important role in physiological responses. 
The  main  groups  include  quinones  (or  phenolic  precursors), 
metal  complexes  (or  complexors),  aromatic  nitro  compounds   
(or reduced hydroxylamine and nitroso derivatives), and conju-
gated imines (or iminium species). In vivo redox cycling with 
oxygen can occur giving rise to oxidative stress (OS) through 
generation of reactive oxygen species (ROS), such as hydrogen 
peroxide,  hydroperoxides,  alkylperoxides,  and  diverse  radicals 
[hydroxyl, alkoxyl, hydroperoxyl and superoxide (SO)]. In some 
cases, ET results in interference with normal electrical effects, 
e.g., in respiration or neurochemistry. Generally, active entities 
possessing ET groups display reduction potentials in the physi-
ologically responsive range, i.e., more positive than -0.5 V. ET, 
ROS and OS have been increasingly implicated in the mode of 
action of drugs and toxins, e.g., anti-infective agents,1 anticancer 
drugs,2 carcinogens,3 reproductive toxins,4 nephrotoxins,5 hepa-
totoxins,6  cardiovascular  toxins,7  nerve  toxins,8  mitochondrial 
toxins,9 abused drugs,10 ototoxins,11 pulmonary toxins,12 immune 
system toxins13 and various other categories of drugs and toxins, 
including human illnesses.14
There is a plethora of experimental evidence supporting the 
OS theoretical framework, including generation of the common 
ROS,  lipid  peroxidation,  degradation  products  of  oxidation, 
depletion of antioxidants (AOs), and DNA oxidation and cleav-
age products, as well as electrochemical data. This comprehensive, 
unifying mechanism is in keeping with the frequent observa-
tions that many ET substances display a variety of activities, e.g., 
multiple drug properties, as well as toxic effects. Knowledge of 
events at the molecular level can result in practical application 
in medicine.
It  is  instructive  to  examine  the  basic  biochemistry  of  ET 
functionalities  in  more  detail.  Redox  cycling  occurs  between 
hydroquinone and p-benzoquinone, and between catechol and 
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Cocaine Metabolism16
These  data  provide  insight  concerning  MK-801  mechanism. 
Cocaine (2) is mainly metabolized by two distinct pathways in 
humans.17  The  major  transformation  consists  of  hydrolysis  of 
the ester groups, which is apparently not important in the toxic 
manifestations. The minor route (Scheme 1) is an oxidative one 
involving the amine moiety, which has attracted most attention 
relative to some toxic responses. Possible metabolites participating 
in the effects of (2), in addition to the drug itself, are norcocaine 
(4), norcocaine nitroxide (5), N-hydroxynorcocaine (6), norco-
caine nitrosonium (7), cocaine iminium (3), and formaldehyde.
Oxidative metabolism of (2) yields norcocaine (4), evidently 
via the iminium derivative (3).17 Microsomes in the brain and 
liver further oxidize (4) to the nitroxide (5). This radical is stabi-
lized by delocalization over O and N, and apparently by intramo-
lecular interaction with n-electrons on the ester substituent. The 
transannular effect which has ample precedent, might well apply 
to other radical species involved in redox cycling in the cocaine 
system, as well as to magnitude of the reduction potential.
Another metabolite is the N-hydroxy derivative (5) (a hydrox-
ylamine) which arises from (4) by a sequence comprising electron 
and proton uptake in reversible manner. The duo of (4) and (5) 
apparently operates as a couple.17,18 This system bears resemblance 
to the one comprising aromatic nitroso compounds (ArNO)-
aromatic hydroxylamine (ArNHOH) which redox cycles with 
participation of the ArNHO· radical.3
An alternate redox cycle entails electron loss by (5) to form 
nitrosonium cation (7) (oxoammonium) reversibly. Which could 
redox cycle with (8). This aspect has been the object of less 
attention.
There have been numerous examples concerning involvement 
of iminiums in drug or toxic action by way of ET-OS.1-5 Bioactive 
o-benzoquinone with generation of superoxide via ET to oxy-
gen.  Semiquinones  act  as  intermediates.  Various  amino  acids 
can operate as electron donors. Superoxide serves as precursor 
to a variety of other ROS. The quinones can belong in either the 
endogenous or exogenous category. In the case of aromatic nitro 
compounds, the reduced nitroso and hydroxylamine metabolites 
can similarly enter into redox cycling, including an oxy radical 
intermediate. This class is only in the exogenous group and is 
related to MK-801 metabolism. Less known are conjugated imi-
nium compounds, of which paraquat is a predominant member.
This review demonstrates that the ET-ROS-OS unifying 
theme, which has been successful for many other classes of 
drugs and toxins, can also be applied to MK-801 which is a 
bicyclic secondary amine. Various biochemical properties of 
the drug are addressed, based on the ET-ROS-OS perspec-
tive. The in vivo activities include anesthetic, anticonvulsant, 
interaction in the brain, neurotoxicity, neuro protection, inter-
action with abused drugs, motor effects, receptor interaction, 
behavior, learning and memory. Metabolic evidence points to 
two main routes whereby ET may be induced, namely, hydrox-
ylamine and phenol formation. Hydroxylamines can undergo 
redox  interactions  involving  nitroxides  and  nitrosonium 
(oxoammonium) species. Analogy is provided based on simi-
lar  transformations  with  cocaine,  3,3'-iminodipropionitrile, 
and phenylhydroxylamine. The phenolic metabolites are well 
known precursors of ET quinones. Also, receptors and pro-and 
anti-oxidant actions are treated.15
However, it should be emphasized that physiological activity 
of endogenous and exogenous substances is often complex and 
multifaceted. Our objective does not encompass extensive treat-
ment of other modes of action. The citations are usually repre-
sentative, rather than exhaustive. A number of original references 
may be found in the reviews and articles cited.
Scheme 1. Cocaine metabolism. There is similarity to MK-801 in relation to involvement of a secondary-amine (4) with subsequent metabolism to 
a hydroxylamine (6). Various studies also report participation of nitroxide (3) and nitrosonium (7). There is evidence for redox cycling entailing ET pro-
cess with subsequent formation of ROS in some cases. The CNS may be involved in the ET reactions. Toxicity might reflect harmful effects from ROS 
generation.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  15
tert-amines are believed to be widespread source of this function-
ality.19 Application to cocaine was made in 1988,17 followed more 
recently by speculation that long-term exposure to cyclic tert-
amines, such as cocaine, may result in biochemical lesions via 
reactive metabolites, e.g., iminium types, thought to be primar-
ily responsible for neurotoxicity.20 Usually, iminiums that partici-
pate in ET are conjugated types.1-5 Exceptions appear to be those 
that attain stabilization of the derived radical by intramolecular 
interaction with n-electrons, as in the case of cocaine or phency-
clidine (PCP).21
Although electrochemistry can provide valuable mechanistic 
insight, unfortunately, it has received little attention in the medic-
inal chemistry area. If the reduction potential is more positive 
than -0.5 V, then there is the possibility of ET in the biological 
domain. Electrochemical studies with nitroxide (5) yielded a 
reduction potential of -0.48 V, indicating a conceivable role in 
redox cycling in vivo with production of OS via ROS.17 Only 
a small quantity of minor metabolites is required to generate 
large quantities of ROS since the operation is catalytic.
Brain microsomal reduction of norcocaine nitroxide gen-
erates SO.22 Incubation of liver microsomes with either the 
nitroxide or the N-hydroxy derivative leads to lipid peroxida-
tion, the degree of which is greater for the metabolites than for 
cocaine itself,23 indicating the crucial role of the metabolites in 
toxicity. Redox cycling involving the metabolites is believed to 
take place, accompanied by formation of SO and lipid peroxyl 
radicals.18 Immunotoxicity in rats is promoted by N-oxidative 
metabolism, evidently via OS, accompanied by depletion in 
GSH.25 Formaldehyde, an oxidative metabolite of 2 (Fig. 1)24 
is reported to produce ROS.14
3,3'-Iminodipropionitrile Metabolism16
3,3'-Iminodipropionitrile  (IDPN),  HN(CH2CH2CN)2,  an 
industrial intermediate, is used as an experimental neurotroxin.16 
Which might be related to (2) mechanistically. Administration 
produced a significant increase in malondialdehyde and decrease 
in vitamin E and glutathione (GSH), suggesting a role for ROS 
in toxicity.26 Concurrent use of Se significantly inhibited IDPN-
induced neurobehavioral changes in rats, and reduced ROS pro-
duction, evidently through attenuation of toxicity by decreased 
lipid  peroxidation.27  Co-treatment  with  cysteamine  protected 
rats against dyskinesia by IDPN.28 Depletion of vitamin E and 
GSH through toxic action was alleviated by the thiolamine as 
AO.  Similarly,  adjuvant  use  of  salicylate  decreased  abnormal 
neurobehavior and reversed GSH depletion, presumably by AO 
action of the phenol.29
Little is known about the action mechanism of IDPN. A clue 
is provided by one of several metabolites, namely the neurotoxic 
N-hydroxy derivative produced by flavin monooxygenase-medi-
ated oxidation.30 The data suggest that metabolism is necessary 
for certain neurotoxicities. There is similarity between IDPN 
and cocaine, both in structure and metabolism. By analogy with 
(6), the N-hydroxy form could operate in a redox cycle with 
the  nitroxide  radical,  or  nitrosonium  could  be  involved.  The 
ester and cyano substituents in the two toxins may play similar 
Figure 1. Diazocilpine MK-801. This secondary-amine is addressed 
mainly in connection mechanism and physiological activity. Metabolism 
yields a hydroxylamine which may be associated with redox entities 
(Fig. 2), as in the case of cocaine. There is also similarity to 3,3'-imi-
nodipropionitrile and phencyclidine. Mk-801 possesses a large number 
of physiological effects involving anesthesia, anticonvulsant, the CNS, 
memory, behavior, learning, fear and analgesia.
Figure 2. Phencyclidine and metabolites. Phencyclidine (PCP) (9a) has 
been extensively investigated as an abused drug. Mechanistic insight is 
gained from metabolic studies that show formation of iminium (9b). The 
electroreduction of 9b is facilitated by the aromatic nucleus despite lack 
of conjugation, indicating through space delocalization of the radical 
product. A computational report also supports this type of stabilization. 
MK-801 bears analogy by the presence ofa beta-nitrogen possessing 
radical character from electroreduction of nitrosonium.16  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 1
and C8 may conceivably play a role. Phenols are well-known 
metabolic precursors of ET quinones.
Receptors
MK-801 binds at two sites on the NMDA receptor-ion channel 
complex, which is a glutamate (Glu) receptor.40 Glu is a main 
excitory neurotransmitter in the brain. The drug attaches to the 
ion channel at the PCP binding site of the receptor, requiring 
depolarizartion of the neuron. Receptor blockage by MK-801 
occurs in a voltage-dependent manner. Our proposed ET mecha-
nism with accompanying electrical effects is in keeping with the 
receptor phenomena.
In a recent publication, the sub-unit mechanisms and proton 
sensitivity of NMDA receptor channel block were discussed.41 
The transient ischemia during occlusive stroke triggers changes 
in the nature of the extracellular milieu, including strong acidi-
fication of the ischemic core with more modest acidification of 
penumbral regions. NMDA receptors are inhibited by protons 
at pH 6.9–7.3, suggesting that even modest acidification could 
reduce or delay the contribution of NMDA receptors to neu-
ronal death until pH gradients surrounding the ischemic insult 
dissipate.  Mutagenesis  studies  of  NMDA  receptor  subunits 
suggest that residues in the linker regions connect the agonist 
binding domain to the transmembrane pore-forming elements 
proton-sensitive gating. The authors show the binding capa-
bilities of several proton-dependent channel blockers, kinetic 
modeling and single channel experiments using acidic extracel-
lular pH, which reduce receptor open probability, increases the 
association rate of optical isomer (-)MK-801, but not isomer (+)
MK-801.
Iron is thought to play a critical role in pathogenesis of neu-
rodegenerative disorders, as Parkinson’s and Alzheimer’s diseases, 
by the generation of oxygen-free radicals in association with oxi-
dative stress. Ferrous chloride markedly inhibited, in a concen-
tration dependent manner, dizolcilpine binding to an open ion 
channel associated with NMDA receptor in rat brain synaptic 
membranes. Addition of an NMDA agonist, such as, spermi-
dine, attenuated the inhibition of MK-801 binding. The results 
suggest that ferrous ions may interfere with opening processes 
of the native NMDA channel through molecular mechanisms 
peculiar to neuronal development in a manner associated with 
the polyamine recognition domain.42
Oxidative Stress
A  study  with  MK-801  showed  that  induced  neurotoxicity   
involved OS in the prefrontal cortex of rats.43 A protective effect 
was shown by caffeic acid phenethyl ester (CAPE) an inhibitor 
of  ROS  generation.44  Induction  of  schizophrenia  by  MK-801 
resulted in significant OS, involving increases in malondialde-
hyde  and  protein  carbonyl  levels.45  Administration  of  CAPE 
reduced  the  detrimental  histopathological  changes.  The  drug 
influences lipid metabolism and the intensity of lipid peroxida-
tion.45 MK-801-induced neurotoxicity causes OS in the prefron-
tal cortex of rats.43
roles in intramolecular stabilization of the nitroxide radical and   
other reactive intermediates.
Phencyclidine (PCP) Metabolism
MK-801 has been designated a PCP-type drug.31 Results suggest 
that mode of action involves PCP receptors, not opioid types. 
Other  results  suggest  that  MK-801  induced  hyperlocomotion 
may be mediated by NMDA receptor antagonism.32 The data 
were similar to those for PCP. PCP-like drugs, such as MK-801, 
have many effects in common, including impact on learning and 
performance.33 Similarity of the two drugs in various studies may 
indicate a similar mechanism entailing ET.
Theoretical studies on PCP provide useful insight.21 It is well 
established that oxidative metabolism of PCP (9a) leads to the 
iminium  species  9b.  Although  9b  is  not  directly  conjugated 
with the aromatic nucleus, cyclic voltammetry studies indicated 
interactive stabilization of the reduced species. Recently, com-
putational studies were performed on the energetics of electron 
uptake by 9b with respect to conformation. In relation to the 
reduced species, thermodynamic preferences were found for con-
formations similar to that present in PCP bound to the active 
site. The through space delocalization is depicted in 9c. The cal-
culations suggest that a factor in the biological responses may be 
ET by the iminium metabolite.
MK-801 Metabolism
A metabolic report provides important insight concerning the 
mechanism of MK-801 action.34 With labeled drug, radioactiv-
ity was widely distributed among various tissues. Major metabo-
lites were the N-hydroxy derivative, and the 2- and 8-hydroxyl 
analogs involving oxidation at carbon. The N-OH (hydroxylam-
ine) product is the focus of our attention. Related literature (see 
above) demonstrates that subsequent oxidation products, such as 
nitroxide and nitrosonium ion can play an important mechanis-
tic role.
MK-801 ET Mechanisms
There are various means whereby the hydroxylamine-nitroxide 
redox coupling could operate. The main ones have been pointed 
out in the cocaine section. Other relevant reports exist. Results 
indicate  that  dismutation  of  superoxide  is  catalyzed  by  the 
oxoammonium/nitroxide  redox  couple  for  carbocyclic  nitrox-
ide derivatives.35 Complexes were studied in which nitrosonium 
served as acceptor with aromatic donors.36,37 The oxoammonium 
cation can be generated by reaction of nitroxide with various 
radicals.38 Nitroxides might act as both anti- and pro-oxidants. 
Other nitrosonium ions and nitroxide can be generated in vivo 
and might serve in cell signaling and as cytotoxic agents.39 Hence, 
there exists ample analogy for assigning a role for the hydroxy-
lamine-nitroxide couple, together with associated species, in the 
bioactivity of MK-801. There is similarity to PCP in relation to 
nitrogen with radical character in the beta position to the aro-
matic ring. Alternatively, the phenolic metabolites formed at C2 www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  17
The resulting flow of electrons from ET would generate electri-
cal fields, thereby affecting ion movement in membrane channels 
and nerve synapses.
Brain Electrochemistry
A study of brain field potentials revealed a particular pattern 
of charges which was very stable over time.56 Higher doses of 
MK-801 produced a continuous change from power decreases 
to increases, accompanied by strong behavioral effects involving 
impaired locomotor control. Changes in the frequency content 
of the field potentials occurred over time. The present authors 
believe that the electrical effects may be related to ET properties 
of the MK-801 metabolites.
Other Brain Effects
MK-801 failed to reduce infarct size in animals whose body tem-
perature rose during ischemia. In contrast, the drug markedly 
reduced infarct volume in temperature controlled animals. The 
results suggest that amelioration of focal cerebral ischemia can-
not be expected if body and brain temperature is allowed to rise 
above normal.57
Gao et al. showed phencyclidine and MK-801 exert time-
dependent effects on the expression of immediate early genes 
in rat brain.58 The mRNA expression pattern for four different 
immediate early genes was examined dynamically in rat brain 
after administration of PCP or MK-801. Following each treat-
ment, the expression of mRNA changed. The authors suggest 
functional  consequences  of  PCP-  or  MK-801-induced  reduc-
tion in NMDA-sensitive glutamate transmission may be relevant 
to  an  understanding  of  animal  NMDA  pharmacology  and/
or to clinical psychotomimetic side effects of antiglutamatergic 
treatments.
Bilateral injection of dizocilpine into the anterior thalamus of 
rat brain induced HSP70 protein formation in pyramidal neu-
rons in deep layer III retrosplenial cortex. This bilateral blockade 
of NMDA receptors in the anterior thalamus by MK-801 injures 
neurons in retrosplenial cortex.59
Delta sleep-inducing peptide has been shown to increase the 
resistance of rats to stress. Increase in the expression of the early 
c-fos in the paraventricular nucleus of the hypothalamus is regarded 
as  the  primary  response  of  animals  in  conditions  of  emotional 
stress. Injection of the peptide leads to decrease in stress-induced 
c-fos expression in the paraventricular nucleus of the hypothala-
mus. Exposure to MK-801 blocks the effects of delta sleep-inducing 
peptide-induced suppression of c-fos gene expression.60
CNS Effects: Neurotoxicity and Neuroprotection  
by MK-8018
NMDA  antagonists,  such  as,  MK-801,  disrupt  sensorimotor   
gating in rats, suggesting that the effects may provide a model 
of such deficits exhibited in schizophrenia.61 MK-801, a non-
competitive NMDA receptor antagonist, is a well known neu-
roprotectant  in  models  of  stroke,  trauma,  Parkinsonism  and 
Anesthesia
Results indicate that blockage of the central NMDA receptor 
may contribute to the production of anesthesia.46 The ability 
of the receptor antagonists to increase the potency of general 
anesthetics paralleled their potency as NMDA antagonists and 
their affinity for the PCP receptor site of the NMDA receptor-
ionophore complex: MK-801 > PCP > ketamine. MK-801 is 
not used clinically as an anesthetic due to development of brain 
lesions.
The discriminative stimulus effect of MK-801 in ketamine-
trained rats was investigated.47 The results indicate that both 
drugs may share a common mechanism of action, which is related 
to the phencyclidine recognition site in the brain.
A recent report lends credence to the ET approach in anes-
thetic action involving propofol.48 Four years ago, a novel unify-
ing hypothesis was advanced for addiction and toxicity by abused 
drugs involving ET.10 One of the principal ET agents is the qui-
none group which is often generated metabolically. Appreciable 
numbers of abused drugs appear to function by the quinone 
route, including amphetamine, methamphetamine, ecstasy, mor-
phine, heroin, phenobarbital and aspirin. Recently, two members 
were added to the quinone category, namely, mescaline49 and 
psilocybin.50
Inflated rates of opioid addiction among anesthesiologists may 
be caused by chronic exposure to low doses of anesthetic agents, 
such  as  propofol  (2,6-diisopropyl  phenol),  in  the  operating 
room.51 Such second-hand exposure results in neuro sensitization 
of the reinforcing effects of the anesthetic, making later addiction 
more likely. Second hand exposure could occur by inhalation or 
skin contact. Other factors may be involved.
Various reports on metabolism of propofol provide insight 
concerning action mechanism. Analysis of products from oxi-
dative metabolism revealed the presence of 2,6-diisopropyl-1,4-
quinone,52 in addition to the quinone dimer (diphenoquinone).53 
More specifically, it is reasonable to focus on involvement of ET 
processes and electrical fields. The radical anion semiquinone 
provides molecular electrostatic potential. Since ET by quinone 
is often associated with generation of ROS, these radicals, at low 
levels, may play a role. At high concentrations, toxicity could 
result.10 There has been scant attention paid to action mode at 
the molecular level. These results provide additional support for 
the hypothesis based on ET by addictive agents.
Anticonvulsants
MK-801 is a potent anticonvulsant which displays high affinity 
for binding sites in rat brain membranes, particularly in the hip-
pocampus.54 None of the major neurotransmitters was active at 
these sites. The only competitive substances were those that block 
the  responses  of  excitatory  amino  acids  mediated  by  NMDA 
receptors, including phencyclidine and ketamine. These findings 
provide a clue to the action mechanism.
Also, a 1992 review advanced the proposal that ET may be 
a possible mode of action for anticonvulsants.55 The conjugated 
iminium functionality is a common one among the active drugs. 18  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 1
acts as an antioxidant against both free radicals and excitory 
amino acids in epilepsy.70
L-2-Chloropropionic acid, when administered orally to rats, 
produces selective necrosis to the granule cell layer of the rat cer-
ebellum, which is delayed in onset, after exposure. Administering 
MK-801 afforded partial protection against the toxicity.71
The effect of pro-inflammatory cytokine interleukin IL-1β on 
the hippocampal slices from neonatal Sprague Dawley rats was 
examined, and neuroprotective action by MK-801 and vitamin-
E analog trilox was shown. The neuroprotective effects suggest 
that free radicals and NMDA receptor-mediated processes are 
involved in IL-1β induced neurodegeneration.72
Organophosphates  and  carbamate  inhibitors  acetylcholin-
esterase produce seizures and lethality in mammals. MK-801 
blocked these seizures. Results suggest that NMDA receptors 
seem critical to such seizures.73
Motor Activity, Learning and Memory
Glutamate transmission plays an important role in many behav-
ioral systems, including motor activity, learning, and memory. 
The noncompetitive NMDA receptor antagonist MK-801 has 
been shown to increase motor activity and to impair learning and 
memory in a variety of tasks in rats, mice and other species.
Many  agents,  e.g.,  MK-801,  that  antagonize  the  NMDA 
receptor-channel complex also cause disturbances of motor coor-
dination.74 The effects of MK-801 upon motor activity and mem-
ory of rats were assessed in behavior testing. The results indicated 
MK-801 can produce profound effects upon motor activity and 
memory, and that these two effects can be dissociated.75
The long-lasting effects of a single high dose treatment with 
MK-801 on water maze performance of rats was reported. The 
drug-treated rats learned to find the escape platform at a slower 
rate than control animals and showed increased thigmotaxis dur-
ing acquisition of the task.76 A study demonstrated that MK-801 
impairs working memory of conscious monkeys. In addition, 
acute and chronic MK-801 produces different effects on receptor 
D1, D2 and generally lowered glutamate and dopamine levels in 
prefrontal cortex.77 The effects of MK-801 on learning ability in 
non-human primates were investigated. MK-801 impaired acqui-
sition of visuo-spatial tasks requiring spatial responses to colored 
objects, and perceptually difficult visual discrimination tasks.78
MK-801 Induced Behavior
MK-801 in rats induced characteristic behavioral syndrome with 
ataxia, stereotypies and hyperlocomotion. Part of the behavioral 
syndrome is thought to be related to interactions between glu-
tamatergic  and  dopaminergic  neurotransmission,  suggesting 
serotonin involvement.79 In a related study involving psychotic-
like behavior induced by MK-801 and serotonin receptors, the 
authors conclude that there is an interaction between NMDA 
and seratonin receptors.80
With zebrafish as a neurobehavioral model, MK-801 increases 
circling behavior, alters swimming activity, and impairs place 
preference.81  Data  indicate  that  systemic  administration  of  a 
organophosphate-induced seizures. Despite this, MK-801, like 
other phencyclidine receptor ligands, such as phencyclidine, ket-
amine or tiletamine, induces psychotic behavior and neuronal 
degeneration. MK-801 exposure caused neuronal degeneration in 
rat axon terminals, microglia, retrospinal cortex, neurons in the 
pyriform, and entorhinal cortices, in amygdala in tenia tecti, and 
in the temporal dentate gyrus.62
MK-801 affected the nervous system of male and female rats 
differently.63 Female rats indicated higher sensitivity to MK-801 
neurotoxicity;  Authors  suggest  the  possible  involvement  of 
17β-estradiol in the sex differences of the sensitivity. The female 
rats also showed increased glial fibrillary acidic protein when 
treated with MK-801 vs. the male rats.
Non-competitive NMDA antagonist MK-801 and phencycli-
dine increase glucose metabolism in many brain areas and induce 
cytoplasmic vacuoles, heat shock protein and necrotic cell death 
in neurons of the rodent posterior cingulate and retrosplenial 
cortex. Administration of radical scavengers (dimethyl sulfoxide 
and α-tocopherol), produced marked attenuation of MK-801-
induced neuronal necrosis. This supports the hypothesis that OS 
plays a role in MK-801-induced neuronal necrosis since patho-
logical changes are attenuated by several AOs.64
Glutamate, the most widely used excitory amino acid trans-
mitter  in  the  brain,  stimulates  ionotropic  and  metabotropic 
receptors. There is an increased release of glutamate after cere-
bral ischemia or hypoxia which cause overstimulation of its 
receptors, leading to an increase in the cellular Ca2+ concentra-
tion. Elevation of Ca2+ is assumed to set various pathological 
processes into motion which degenerate neurons by activating 
proteases, lipases, endonucleases and nitric oxide synthases and 
by promoting the formation of free oxygen radicals. MK-801-
treated  cultures  of  rat  hippocampal  neurons  showed  a  neu-
roprotective effect.65 The influence of MK -80 1 on release of 
inhibitory amino acids in the field of neuroprotection against 
ischemic  injury  was  explored.  The  protection  against  brain 
damage induced by ischemia, at least partly, is related to inhi-
bition of calcium influx and, more significantly, blockage of 
excitory amino acid release from ischemic synaptosomes.66 In a 
related study, paraquat or xanthine oxidase was shown to acti-
vate the NMDA receptor and the resultant excitory amino acid 
glutamate  leads  to  excitotoxicity.  Dizocilpine  attenuates  this 
oxidant injury, acting as an AO.67
In  vitro  studies  have  demonstrated  that  NMDA  receptor 
activation  rescues  cerebellar  granule  neurons  from  apoptotic 
death.  Mechanism  involves  MK-801  inhibiting  the  caspase 
activation.68 Nitroxyl anion (NO-), and/or its conjugate acid, 
HNO, may be formed in the cellular milieu by several routes 
under  both  physiological  and  pathophysiological  conditions. 
Reactive nitrogen oxide species can contribute significantly to 
cerebral ischemic injury. A study using Angeli’s salt, a spontane-
ous HNO/NO- generating compound, showed time- and con-
centration-dependent increase in neural cell death. Addition of 
glutamate receptor antagonist MK-801 to the culture reduced 
the toxicity, acting as an antioxidant.69 In a related study, low 
doses of MK-801 were shown to protect iron-induced oxidative 
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amphetamine-induced release of amino acids and acetylcholine 
in rat brain. Part of the effect reflects action as an AO.89
Methamphetamine  causes  long-term  toxicity  to  dopamine 
nerve endings of the striatum. In vivo experiments show that 
MK-801 ability to protect against methamphetamine neurotox-
icity is related to their common property as blockers of microglial 
activation.90
Another drug in this category is mescaline (peyote) whose 
mode  of  action  has  been  discussed  recently.49  The  proposed 
mechanism entails demethylation to a catechol moiety which 
then has the potential of redox cycling with an ET o-quinone. 
Electrochemical effects may be involved in the hallucinogenic 
and other effects.
MK-801/NMDA Receptor and Bioactivity
The prior sections illustrate the variety of this drug in the bio-
logical realm. The following portion provides recent literature 
from 2008–2009 dealing with memory, behavior, learning, fear, 
pain control and anesthesia.
Various literature reports address the role of MK-801 in mem-
ory. Inhibition of NMDA Glu receptors during food aversion 
conditioning reactivation initiated disruption of long-term mem-
ory.91 Injection of MK-801 produced a decrease in the number 
of conditioned food aversions. The long-term memory reactiva-
tion disruption induced two stages of amnesia development. The 
NMDA Glu receptor is implicated in memory formation and 
consolidation.92  Administration  of  MK-801  immediately  after 
training impaired inhibitory avoidance performance, suggesting 
induction of state-dependent recall. NMDA receptor antagonists 
induce amnesia.93 Data revealed that MK-801 produced antero-
grade  and  retrograde  amnesia.  Pharmacological  disruption  of 
reconsolidation of alcohol-associated memories can be achieved 
by use of NMDA antagonists, such as MK-801.94 This may be a 
therapeutic strategy for prevention of relapse in alcohol addiction. 
Studies were made of MK-801 involvement in working memory 
processing in the medical prefrontal cortex.95
MK-801 has been employed in behavioral studies. Deficits 
in behavior were noted following treatment by NMDA antago-
nists, such as MK-801. More specifically, there was increased 
anxiety-like behavior.96 The effects of MK-801 treatment on 
rat behavior were observed after neonatal lesions of the ento-
rhinal cortex.97 The combined treatment may serve to model 
certain  aspects  of  psychiatric  behavior.  A  genetically-inbred 
mouse  strain  shows  heightened  sensitivity  to  the  ability  of 
MK-801  to  raise  the  threshold  voltage  necessary  to  precipi-
tate tonic hindlimb extension and elicit irregular episodes of 
intense jumping behavior.98 The heightened behavioral sensi-
tivity to MK-801 does not appear to result from alterations of 
expression of the NMDA receptor protein subunits. Behavioral 
flexibility refers to the ability to modify ongoing behavior in 
response to changing goals or environmental contingencies.99 
Administration of MK-801 significantly impaired task perfor-
mance. The amygdala appears to be a primary locus in medi-
ating the effects of drug stimuli on subsequent drug-seeking 
behavior.100 The NMDA subtype of the Glu receptor within 
relatively  small  dosage  of  MK-801  facilitates  performance 
when reward is small. Facilitation may be due to the rein-
forcement of mechanisms that work in opposition to response 
bias.82
Circadian Behavior and Sleep Induction
The NMDA receptor antagonist MK-801 blocks the phase shift-
ing effects of light on the circadian rhythm in hamsters.83 A dose-
dependent blockade of both light-induced phase advances and 
delays occurred. The data indicated an important role for excit-
atory amino acid receptor in transmission of light information 
from the retina to the circardian system.
A commonly used sleep inducer is zolpidem (Ambien).84 A 
proposed action mechanism comprises protonation to a conju-
gated pyridinium (iminium) structure which may function as an 
ET agent. Electrochemical phenomena may be responsible for 
sleep induction and adverse side effects.
Abused Drugs
Upon repeated exposure to drugs of abuse, the gradual develop-
ment of tolerance, dependence and sensitization is thought to 
play a crucial role in the psychopathology of drug additiction.85 
In recent years, NMDA receptor antagonist MK-801 has been 
widely used to investigate the involvement of NMDA receptors 
in drug-induced neuroadaptations. Dizocilpine shares stimulus 
properties with phencyclidine and, to lesser extent, with etha-
nol. Dizocilpine was found to potentiate the reinforcing proper-
ties of morphine and cocaine in models. Regarding the cerebral 
sites where dizocilpine might exert its reinforcing effects, several 
areas were designated as likely candidates. However, dizocil-
pine and morphine were found to dramatically enhance lethal-
ity. Dizocilpine was shown to prevent, as well as enhance, the 
development of drug-induced behavioral effects, and appears 
to induce sensitization to its own behavioral effects, as well as 
cross-sensitization to drugs of abuse.
Studies were carried out on rats implanted with morphine.86,87 
The naloxane-precipitated abstinence syndrome in rats exposed 
to MK-801 was more intense than controls, whereas the absti-
nence syndrome in rats that received MK-801 before naloxane 
injection was less intense. The intensification is attributed to 
increase in upregulation and supersensitivity of NMDA recep-
tors caused by morphine. The attenuation is explained based 
on blockage by MK-801 of NMDA receptors. Related studies 
are reported for morphine and MK-801. The present authors 
believe ET events may be involved in line with the recent unify-
ing hypothesis for abused drugs.10
In a related study, results indicate that MK801 not only blocks 
the development of morphine-induced conditioned place prefer-
ence, but it is also able to block the expression of a conditioned 
response that has been acquired.88
Glutamate  receptor  activation  participates  in  mediation  of 
neurotoxic  effects  in  the  striatum  induced  by  the  psychomo-
tor  stimulant  amphetamine.  MK-801  inhibits  amphetamine- 
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but spared extinction learning about familiar stimuli. Long-term 
fear memory can be extinguished by disruption of reconsolida-
tion of specific memories associated with the fear response.108 
The effects of MK-801 on memory reconsolidation were studied. 
Neurotrsansmitters that are important for extinction of condi-
tioned fear in adult rats are not important for extinction in young 
rats.109 Pre-extinction injection of MK-801 has no effect on extinc-
tion in young rats, whereas it impairs long-term extinction in older 
rats.
In relation to pain control, the mechanism of orthodontic pain 
is poorly understood.110 By use of a behavioral model, application 
of both systemic and peripheral MK-801 and morphine exerted 
an analgesic effect. Face-grooming behavior is a reliable measure 
for tooth pain in rats. Cyclooxygenase-2 (COX-2) is upregulated 
and plays an important role in pain and hyperalgesia induced 
by nociceptive stimulation.111 Activation of the spinal NMDA 
receptor might contribute to the upregulation of COX-2 spinal 
expression. Results show that injection of MK-801 suppressed 
the upregulation of the COX-2 expression and characteristic pain 
behavior responses.
In a study of anesthetics, classical ones of the gamma-amin-
obutyric  acid  (GABA)  type  A  receptor-enhancing  class,  e.g., 
phenobarbital and chloral hydrate, produce analgesia and uncon-
sciousness (sedation).112 Dissociative anesthetics that antagonize 
the NMDA receptor, e.g., MK-801, ketamine and PCP, produce 
analgesia,  but  do  not  induce  complete  loss  of  consciousness. 
From a mechanistic study, the authors hypothesize that neural 
substrates of sleep-wake behavior are engaged by low-dose seda-
tive  anesthetics,  and  that  the  mesopontine  descending  nora-
drenergic cell groups contribute to the analgesic effects of both 
NMDA receptor antagonists and GABA (A) receptor-enhancing 
anesthetics.
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the  amygdala  is  important  for  consolidation  of  associations 
between environmental conditioned stimuli and the effects of 
additive drugs. Systemic antagonism of NMDA receptors with 
MK-801 before memory reactivation reduced acquired drug-
seeking behavior that depends on drug-associated cues acting as 
conditioned reinforcers. Such drugs may be useful in treatment 
of relapse prevention in drug addiction.
Effect on learning has been examined for MK-801. Food aver-
sion  conditioning  consolidation  was  investigated  with  various 
substances in snails.101 The conditioning was absent after molecu-
lar mechanisms evoked disruption of long-term memory consoli-
dation during learning. Treatment of mice with MK-801 induced 
learning  impairment,  accompanied  by  inhibition  of  NMDA-
stimulated phosphorylation.102 Ginsenoside Rg 1 improves spatial 
learning capacity impaired by morphine, and restores the mor-
phine-inhibited long-term potentiation.103 This effect is NMDA 
receptor dependent, as evidenced by experiments with MK-801. 
Systemic administration of the drug impairs reversal learning in 
rats.104 The study entailed spatial discrimination. Administration 
of MK-801 before exposure to ethanol significantly inhibited 
ethanol state-dependent learning.105 Dorsal hippocampal NMDA 
receptors are involved in mediating the learning process.
The  influence  of  MK-801  on  fear  has  been  investigated. 
A  study  addressed  whether  Ro-64-6198  impairs  acquisition 
of  fear  conditioning  through  glutamatergic  mechanisms.106 
Administration of Ro-64-6198 and MK-801, either separately or 
concomitantly, reduced the facilitating effects of context expo-
sure. The findings demonstrate the existence of functional antag-
onism between NMDA and nociceptin opioid peptide receptors 
that  predominantly  contributes  to  modulation  of  conditional 
fear learning that involves spatial-processing demands. The role 
of conditioned stimulus familiarity in determining the effects of 
MK-801 on fear extinction was shown to be an important fac-
tor.107 The drug impaired extinction learning about novel stimuli, 
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